Bruker (NASDAQ: BRKR) — Company Overview, News & Financial Data
Bruker develops high-performance scientific instruments for pharma, biotech, clinical, and industrial applications.
Bruker
Bruker is a manufacturer of high-performance scientific instruments and analytical and diagnostic solutions for life science research, materials analysis, and industrial applications. The company develops and supplies technologies including nuclear magnetic resonance spectrometers, mass spectrometry systems, X-ray diffraction and fluorescence analyzers, atomic force microscopes, fluorescence optical microscopy platforms, and high-temperature superconducting wire products. Its instruments enable academic institutions, pharmaceutical and biotechnology companies, clinical diagnostic laboratories, and semiconductor manufacturers to perform structural biology research, cellular imaging, chemical characterization, and quality control.
Snapshot
Operations
Products and/or services of Bruker
- Nuclear Magnetic Resonance Spectrometers: Development and production of ultra-high field NMR systems, EPR instruments, and preclinical imaging systems, including 1.3 GHz spectrometers, serving structural biology, chemistry, and materials science research institutes and university facilities globally.
- Mass Spectrometry Systems: Supply of timsTOF liquid chromatography mass spectrometers, MALDI-TOF systems, and FT-ICR instruments for proteomics, metabolomics, lipidomics, and clinical diagnostics across pharmaceutical, biopharmaceutical, clinical diagnostic, and academic research laboratories worldwide.
- X-Ray and Elemental Analysis Systems: Manufacture of X-ray diffraction, X-ray fluorescence, and energy-dispersive spectroscopy systems, such as S8 TIGER spectrometers and XFlash detectors, used for elemental identification, structural determination, and quality control in industrial facilities.
- Surface Analysis and Atomic Force Microscopes: Provision of atomic force microscopes, 3D optical profilometers, and nanomechanical testing instruments used in semiconductor characterization, 2D materials research, and advanced surface metrology across microelectronics and nanotechnology research facilities worldwide.
- Fluorescence Microscopy and Spatial Biology: Delivery of multiphoton, light-sheet, and super-resolution fluorescence microscopy platforms, single-cell spatial biology systems, and tissue-clearing imaging workflows for neuroscience, immunology, and oncology research across biomedical institutes globally.
- Superconducting Materials and Energy Products: Production of low-temperature and high-temperature superconducting wires, stranded conductors, and specialized magnet components utilized in magnetic confinement fusion power projects, nuclear magnetic resonance, and medical magnetic resonance imaging scanners globally.
Bruker executive team
- Dr. Frank H. Laukien Ph.D.Chairman, CEO & President
- Mr. Gerald N. Herman CPAExecutive VP & CFO
- Dr. Mark R. Munch Ph.D.Corporate Executive VP and President of Bruker Nano Group & Corporate
- Mr. Juergen SregaPresident of Bruker CALID Group & Bruker Daltonics Division
- Dr. Falko Busse Ph.D.President of Bruker BioSpin Group
- Mr. Thomas BuresChief Accounting Officer
- Mr. J. Brent Alldredge J.D.Senior VP, General Counsel, Secretary & Global Head of Compliance
- Dr. Burkhard Prause Ph.D.President and CEO of Bruker Energy & Supercon Technologies, Inc.